Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pregnant Woman With Single Pregnancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02033551
What this trial is testing

A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid Tumors

Who this might be right for
Breast CancerOvarian CancerColon Cancer+3 more
AbbVie 47
Testing effectiveness (Phase 2)Study completedNCT04919512
What this trial is testing

TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder

Who this might be right for
Urinary Bladder Neoplasms
Janssen Research & Development, LLC 163
Early research (Phase 1)Active Not RecruitingNCT06781983
What this trial is testing

Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Innate Pharma 145
Testing effectiveness (Phase 2)Study completedNCT04205630
What this trial is testing

SYD985 in Patients With HER2-expressing Recurrent, Advanced or Metastatic Endometrial Carcinoma

Who this might be right for
Endometrial Cancer
Byondis B.V. 64
Testing effectiveness (Phase 2)Study completedNCT02354586
What this trial is testing

Niraparib in Patients With Ovarian Cancer Who Have Received Three or Four Previous Chemotherapy Regimens

Who this might be right for
Ovarian NeoplasmsOvarian Cancer
Tesaro, Inc. 463
Testing effectiveness (Phase 2)Ended earlyNCT04871529
What this trial is testing

Testing the Addition of an Anti-Cancer Immunotherapy Drug, Avelumab, to Gemcitabine and Carboplatin Chemotherapy Prior to Surgery in Muscle Invasive Urinary Tract Cancer vs. Surgery Alone in Patients Who Are Not Able to Receive Cisplatin Therapy (SWOG GAP TRIAL)

Who this might be right for
Bladder Carcinoma Infiltrating the Muscle of the Bladder WallInfiltrating Renal Pelvis and Ureter Urothelial CarcinomaStage II Bladder Cancer AJCC v8
SWOG Cancer Research Network 6
Early research (Phase 1)Ended earlyNCT03119077
What this trial is testing

Single Ascending Dose, First-in-Human Study on Safety, Tolerability and Pharmacokinetics of BAY1161116

Who this might be right for
Polycystic Ovary Syndrome
Bayer 32
Not applicableNot Yet RecruitingNCT07116239
What this trial is testing

Edoxaban Steady-State PK/PD in Adults With Nephrotic Syndrome

Who this might be right for
Nephrotic SyndromeHypoalbuminemia
Peking University People's Hospital 60
Testing effectiveness (Phase 2)UnknownNCT05310331
What this trial is testing

Donafenib for Recurrent Cervical Cancer

Who this might be right for
Targeted TherapyChemotherapyRecurrent Cervical Carcinoma+4 more
Lei Li 20
Early research (Phase 1)Study completedNCT01419041
What this trial is testing

Evaluate The Pharmacokinetics Of Crizotinib (PF-02341066) In Subjects With Impaired Renal Function

Who this might be right for
Renal Impairment
Pfizer 16
Early research (Phase 1)Active Not RecruitingNCT07168356
What this trial is testing

Evaluate Blood Levels of Bepirovirsen in Adult Participants With Severe or Moderate Kidney Disease

Who this might be right for
Hepatitis B
GlaxoSmithKline 32
Large-scale testing (Phase 3)Active Not RecruitingNCT00131235
What this trial is testing

Gestational Sulfadoxine-pyrimethamine and Azithromycin Treatment to Prevent Preterm Birth

Who this might be right for
MalariaSexually Transmitted DiseasesPreterm Birth+1 more
Tampere University 1,320
Early research (Phase 1)Study completedNCT03055143
What this trial is testing

Study of Doxorubicin in Patients With Metastatic Breast Cancer/Advanced Ovarian Cancer

Who this might be right for
Breast Cancer and Ovarian Cancer
Sun Pharma Advanced Research Company Limited 29
Testing effectiveness (Phase 2)Looking for participantsNCT07420517
What this trial is testing

Dutasteride in Patients With Low Grade Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
Paul Toren 95
Post-approval studies (Phase 4)Study completedNCT01763580
What this trial is testing

Evaluate the Effect of Tacrolimus and Corticosteroid Combination Therapy in Patients With Minimal Change Nephrotic Syndrome

Who this might be right for
MCNSMinimal Change Nephrotic Syndrome (MCNS)
Astellas Pharma Korea, Inc. 144
Large-scale testing (Phase 3)UnknownNCT03240159
What this trial is testing

Long Antagonist Protocol for IVF With Single Luteal Dose of Degarelix

Who this might be right for
Pregnancy, Ovarian
Assisting Nature 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07445308
What this trial is testing

The Study is to Evaluate the Safety and Tolerability of SPGL008 Alone or in Combination With BCG in the Patients With NMIBC, and to Determine the RP2D of SPGL008 Alone or in Combination With BCG.To Evaluate the Preliminary Efficacy of SPGL008 Alone or in Combination With BCG.

Who this might be right for
NMIBC
Shenyang Sunshine Pharmaceutical Co., LTD. 120
Post-approval studies (Phase 4)Study completedNCT03810417
What this trial is testing

Preop Digifab in CABG to Reduce Ouabain Levels and Prevent AKI

Who this might be right for
Acute Kidney Injury
University of Maryland, Baltimore 267
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07454018
What this trial is testing

Iparomlimab/Tuvonralimab + Standard Chemotherapy and Olaparib in Platinum-Sensitive Recurrent Ovarian Cancer

Who this might be right for
Recurrent Ovarian CancerPlatinum-sensitive Ovarian Cancer
The First Affiliated Hospital of Soochow University 45
Early research (Phase 1)Study completedNCT06661733
What this trial is testing

Investigate the Pharmacokinetics, Safety and Tolerability of AZD5462 in Participants With Renal Impairment

Who this might be right for
Renal Impairment
AstraZeneca 16
Next Page